Skip to main content
OpenTrials
Completed

NCT Number: NCT02941900

Interest and Impact of Skin Cancer Genetic Testing

The purpose of this study is to learn whether the patient might be interested in skin cancer genetic testing, and if so, what kinds of thoughts, feelings, and behaviors might result from this testing. Testing for skin cancer risk based on the MC1R gene is not currently used in clinical practice; it will be offered in this study for research purposes only.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Non-Melanoma Skin Cancer (NMSC)

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Memorial Sloan Kettering Cancer Center

New York, 10065, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years of age or older
  • English fluent as we do not have the resources to translate all the materials including the website and risk feedback materials into other languages
  • Prior history of stage 0, I or II NMSC as per EMR or clinical judgment

Exclusion criteria

  • Inability to provide meaningful informed consent due to cognitive or psychiatric disability as determined by the judgement of the consenting professional or clinician

Treatment and study plan

MC1R genotyping

Genetic

MC1R Testing Website

Behavioral

The website includes three educational modules about genetic testing with corresponding knowledge questions.

Baseline Survey

Behavioral

Primary outcomes

  1. number of patients interested in MC1R testing

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Memorial Sloan Kettering Cancer Center

Other

Registry information

Official study title

PERSONALIZED GENOMIC TESTING FOR MELANOMA: MAXIMIZING COMPREHENSION AND HEALTH OUTCOMES IN SKIN CANCER PATIENTS

Important dates

Study start
2016
Primary completion
2023
Study completion
2023
First posted
Oct 21, 2016
Registry last updated
Jan 20, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.